Heterogeneity of immunopathological features of AChR/MuSK autoantibody-negative myasthenia gravis

Journal of Neuroimmunology

Volumn 189, Issue 1-2, 2007, Pages 163-168

  Hayashi, Akio ^a   Shiono, Hiroyuki ^a   Ohta, Mitsuhiro ^b   Ohta, Kiyoe ^c   Okumura, Meinoshin ^a   Sawa, Yoshiki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^c UTANO NATIONAL HOSPITAL   (Japan)

Author keywords

Acetylcholine receptor; Flow cytometry; Germinal center; Muscle specific tyrosine kinase; Myasthenia gravis; Thymectomy

Indexed keywords

AUTOANTIBODY; CHOLINERGIC RECEPTOR ANTIBODY; MUSCLE SPECIFIC TYROSINE KINASE ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GERMINAL CENTER; HUMAN; IMMUNOPATHOLOGY; MALE; MYASTHENIA GRAVIS; PATHOGENESIS; PRIORITY JOURNAL; THYMUS;

ADOLESCENT; ADULT; ANTIBODY SPECIFICITY; AUTOANTIBODIES; B-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; GERMINAL CENTER; HUMANS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CHOLINERGIC; THYMECTOMY; THYMUS GLAND;

EID: 34548499553     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.07.007     Document Type: Article

References (22)

1. Evoli A., Tonali P.A., Padua L., Monaco M.L., Scuderi F., Batocchi A.P., Marino M., and Bartoccioni E. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 126 (2003) 2304-2311
2. Fujii Y., Monden Y., Nakahara K., Hashimoto J., and Kawashima Y. Antibody to acetylcholine receptor in myasthenia gravis: production by lymphocytes from thymus or thymoma. Neurology 34 (1984) 1182-1186
3. Gronseth G.S., and Barohn R.J. Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 55 (2000) 7-15
4. Hoch W., McConville J., Helms S., Newsom-Davis J., Helms A., and Vincent A. Auto-antibodies to the receptor tyrosine kinase MuSK in patient with myasthenia gravis without acetylcholine receptor antibodies. Nat. Med. 7 (2001) 365-368
5. Jaretzki A., Barohn R.J., Ernstoff R.M., Kaminski H.J., Keesey J.C., Penn A.S., and Sanders D.B. Myasthenia gravis: recommendations for clinical research standards. Ann. Thorac. Surg. 70 (2000) 327-334
6. Lauriola L., Ranelletti F., Maggiano N., Guerriero M., Punzi C., Marsili F., Bartoccioni E., and Evoli A. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis. Neurology 64 (2005) 536-538
7. Leite M.I., Strobel P., Jones M., Micklem K., Moritz R., Gold R., Niks E.H., Berrih-Aknin S., Scaravilli F., Canelhas A., Marx A., Newsom D., Willcox N., and Vincent A. Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG. Ann. Neurol. 57 (2005) 444-448
8. Levinson A.I., and Wheatley L.M. The thymus and the pathogenesis of myasthenia gravis. Clin. Immunol. Immunopathol. 78 (1996) 1-5
9. Lindstrom J.M. Acetylcholine receptors and myasthenia. Muscle Nerve 23 (2000) 453-477
10. Ohta K., Shigemoto K., Kubo S., Maruyama N., Abe Y., Ueda N., and Ohta M. MuSK antibodies in AChR Ab-seropositive MG vs AChR Ab-seronegative MG. Neurology 62 (2004) 2132-2133
11. Okumura M., Ohta M., Takeuchi Y., Shiono H., Inoue M., Fukuoka K., Kadota Y., Miyoshi S., Fujii Y., and Matsuda H. The immunologic role of thymectomy in the treatment of myasthenia gravis: Implication of thymus-associated B-lymphocyte subset in reduction of the anti-acetylcholine receptor antibody titer. J. Thorac. Cardiovasc Surg. 126 (2003) 1922-1928
12. Sanders D.B., E.I.-Salem K., Massey J.M., McConville J., and Vincent A. Clinical aspects of MuSK antibody positive seronegative MG. Neurology 60 (2003) 1978-1980
13. Scadding G.K., Vincent A., Newsom-Davis J., and Henry K. Acetylcholine receptor antibody synthesis by thymic lymphocytes. Correlation with thymic histology. Neurology 31 (1981) 935-943
14. Scuderi F., Marino M., Colonna L., Mannella F., Evoli A., Provenzano C., and Bartoccioni E. Anti-p110 autoantibodies identify a subtype of "seronegative" myasthenia gravis with prominent oculobulbar involvement. Lab. Invest. 82 (2002) 1139-1146
15. Shiono H., Fujii Y., Okumura M., Takeuchi Y., Inoue M., and Matsuda H. Failure to down-regulate Bcl-2 protein in thymic germinal center B cells in myasthenia gravis. Eur. J. Immunol. 27 (1997) 805-809
16. Shiono H., Roxanis I., Zhang W., Sims G.P., Meager A., Jacobson J.W., Liu J.L., Matthews I., Wong Y.L., Bonifati M., Micklem K., Stott D.I., Todd J.A., Beeson D., and Vincent A. Scenarios for anti immunization of T and B cells in myasthenia gravis. Ann. N.Y. Acad. Sci. 998 (2003) 237-256
17. Shiraishi H., Motomura M., Yoshimura T., Fukudome T., Fukuda T., Nakao Y., Tsujihata M., Vincent A., and Eguchi K. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis. Ann. Neurol. 57 (2005) 289-293
18. Sims G.P., Shiono H., Willcox N., and Stott D.I. Somatic hyper mutation and selection of B cells in thymic germinal center responding to acetylcholine receptor in myasthenia gravis. J. Immunol. 167 (2001) 1935-1944
19. Vincent A. Unraveling the pathogenesis of myasthenia gravis. Nat. Rev., Immunol. 2 (2002) 797-804
20. Vincent A., Scadding G.K., Thomas H.C., and Newsom-Davis J. In vitro synthesis of anti-acetylcholine receptor antibody by thymic lymphocytes in myasthenia gravis. Lancet 1 (1978) 305-307
21. Willcox N. Myasthenia gravis. Curr. Opin. Immunol. 5 (1993) 910-917
22. Yeh J.H., Chen W.H., Chiu H.C., and Vincent A. Low frequency of MuSK antibody in generalized seronegative myasthenia gravis among Chinese. Neurology 62 (2004) 2131